Skip to content

GENEREX BIOTECHNOLOGY CORP: filings

Every GENEREX BIOTECHNOLOGY CORP annual and quarterly report in the SEC record with the published financial measures it tagged, 39 filings, each linked to its SEC index.

Filing record ends 2021-06-21

The latest filing in this captured record is a 10-Q filed 2021-06-21. No later filing is in the SEC companyfacts record captured on 2026-09-22. GENEREX BIOTECHNOLOGY CORP may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2021-06-21fiscal Q3 2021471280001607062-21-000171
10-Q2021-03-17fiscal Q2 2021461260001607062-21-000056
10-Q2020-12-21fiscal Q1 202044910001607062-20-000353
10-K2020-11-13fiscal FY 202046960001607062-20-000327
10-Q2020-06-22fiscal Q3 2020441200001607062-20-000184
10-Q2020-03-20fiscal Q2 2020441200001607062-20-000067
10-Q2019-12-16fiscal Q1 202042860001607062-19-000475
10-K2019-11-12fiscal FY 201940860001607062-19-000429
10-Q2019-06-19fiscal Q3 2019391030001607062-19-000278
10-Q/A2019-04-16fiscal Q2 201935970001607062-19-000157
10-Q2018-12-24fiscal Q1 201932650001607062-18-000486
10-K2018-10-26fiscal FY 201835720001607062-18-000361
10-Q2018-06-11fiscal Q3 201832860001607062-18-000187
10-Q2018-03-16fiscal Q2 201832860001607062-18-000082
10-Q2017-12-14fiscal Q1 201830560001607062-17-000433
10-K2017-10-26fiscal FY 201733600001607062-17-000349
10-Q2017-06-15fiscal Q3 201728680001607062-17-000228
10-Q2017-03-22fiscal Q2 201624550001607062-17-000109
10-Q2017-01-18fiscal Q1 201619350001607062-17-000024
10-K2017-01-17fiscal FY 201628540001607062-17-000021
10-Q2016-07-22fiscal Q3 201623610001607062-16-000922
10-Q2016-07-22fiscal Q2 201623570001607062-16-000920
10-Q2016-01-14fiscal Q1 201625470001607062-16-000598
10-K2015-10-09fiscal FY 201530600001607062-15-000445
10-Q2015-06-05fiscal Q3 201526730001607062-15-000235
10-Q2015-03-06fiscal Q2 201525670001607062-15-000085
10-Q2014-12-12fiscal Q1 201424490001607062-14-000200
10-K2014-10-03fiscal FY 201430740001607062-14-000128
10-Q2014-06-06fiscal Q3 2014361010001607062-14-000015
10-Q2014-03-07fiscal Q2 2014361020001554795-14-000155
10-Q2013-12-09fiscal Q1 201436760001554795-13-000733
10-K2013-10-11fiscal FY 2013361700001554795-13-000602
10-Q2013-06-10fiscal Q3 2013341220001144204-13-034142
10-Q2013-03-11fiscal Q2 2013311070001144204-13-014108
10-Q2012-12-10fiscal Q1 201335920001144204-12-067267
10-K2012-10-15fiscal FY 2012381930001144204-12-056138
10-Q2012-06-11fiscal Q3 2012361230001144204-12-034225
10-Q2012-03-12fiscal Q2 2012321070001144204-12-014227
10-Q2011-12-12fiscal Q1 201236950001144204-11-069427

Inspect the source

Entity
GENEREX BIOTECHNOLOGY CORP / CIK 0001059784
Captured
SEC response SHA-256
a8779b8c3aa8286320834b30d50af09999238cecacb9e7883d21e11477763a4d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001059784.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))